153 related articles for article (PubMed ID: 38362652)
1. Prescribing trends of proton pump inhibitors and histamine blockers among children in the United Kingdom (1998-2019): A population-based assessment.
Masarwa R; Reynier P; Lefebvre C; Platt RW; Delaney JAC; Filion KB
Pharmacoepidemiol Drug Saf; 2024 Feb; 33(2):e5752. PubMed ID: 38362652
[TBL] [Abstract][Full Text] [Related]
2. Prospective Study of Gastroesophageal Reflux, Use of Proton Pump Inhibitors and H2-Receptor Antagonists, and Risk of Hearing Loss.
Lin BM; Curhan SG; Wang M; Jacobson BC; Eavey R; Stankovic KM; Curhan GC
Ear Hear; 2017; 38(1):21-27. PubMed ID: 27556519
[TBL] [Abstract][Full Text] [Related]
3. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
[TBL] [Abstract][Full Text] [Related]
4. Changes in prescription patterns of acid-suppressant medications by Belgian pediatricians: analysis of the national database, [1997-2009].
De Bruyne P; Christiaens T; Vander Stichele R; Van Winckel M
J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):220-5. PubMed ID: 24464148
[TBL] [Abstract][Full Text] [Related]
5. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
Landi SN; Sandler RS; Pate V; Lund JL
Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
[TBL] [Abstract][Full Text] [Related]
6. The changing patterns of dispensing branded and generic drugs for the treatment of gastroesophageal reflux disease between 2006 and 2011 in Japan: a retrospective cohort study.
Murata K; Hinotsu S; Hamada S; Ezoe Y; Muto M; Kawakami K
BMC Health Serv Res; 2015 Feb; 15():76. PubMed ID: 25885571
[TBL] [Abstract][Full Text] [Related]
7. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
[TBL] [Abstract][Full Text] [Related]
8. Practice patterns of reflux medication prescriptions in otolaryngology compared to other specialties.
Luetzenberg FS; Jiang N
Laryngoscope; 2020 Feb; 130(2):321-327. PubMed ID: 30861137
[TBL] [Abstract][Full Text] [Related]
9. Effect of Gastric Acid Suppressants on Response to a Physical Activity Intervention and Major Mobility Disability in Older Adults: Results from the Lifestyle Interventions for Elders (LIFE) Study.
Squires PJ; Pahor M; Manini TM; Brown JD
Pharmacotherapy; 2019 Aug; 39(8):816-826. PubMed ID: 31230397
[TBL] [Abstract][Full Text] [Related]
10. Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care.
Martin RM; Lim AG; Kerry SM; Hilton SR
Aliment Pharmacol Ther; 1998 Aug; 12(8):797-805. PubMed ID: 9726394
[TBL] [Abstract][Full Text] [Related]
11. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review.
Cohen S; Bueno de Mesquita M; Mimouni FB
Br J Clin Pharmacol; 2015 Aug; 80(2):200-8. PubMed ID: 25752807
[TBL] [Abstract][Full Text] [Related]
12. Pediatric gastroesophageal reflux disease and acid-related conditions: trends in incidence of diagnosis and acid suppression therapy.
Nelson SP; Kothari S; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
J Med Econ; 2009; 12(4):348-55. PubMed ID: 19827992
[TBL] [Abstract][Full Text] [Related]
13. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
Lucas LM; Gerrity MS; Anderson T
Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
[TBL] [Abstract][Full Text] [Related]
14. Gastroesophageal reflux disease: exaggerations, evidence and clinical practice.
Ferreira CT; Carvalho Ed; Sdepanian VL; Morais MB; Vieira MC; Silva LR
J Pediatr (Rio J); 2014; 90(2):105-18. PubMed ID: 24184302
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of children and adolescents first prescribed proton pump inhibitors or histamine-2-receptor antagonists: an observational cohort study.
Ruigómez A; Kool-Houweling LMA; García Rodríguez LA; Penning-van Beest FJA; Herings RMC
Curr Med Res Opin; 2017 Dec; 33(12):2251-2259. PubMed ID: 28562108
[TBL] [Abstract][Full Text] [Related]
16. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.
El-Serag HB; Fitzgerald S; Richardson P
Am J Gastroenterol; 2009 Sep; 104(9):2161-7. PubMed ID: 19568229
[TBL] [Abstract][Full Text] [Related]
17. Use of anti-reflux medications in infants under 1 year of age: a retrospective drug utilization study using national prescription reimbursement data.
O'Reilly D; Conway R; O'Connor L; Fitzpatrick P
Eur J Pediatr; 2020 Dec; 179(12):1963-1967. PubMed ID: 33051717
[TBL] [Abstract][Full Text] [Related]
18. Trends in acid suppressant drug prescriptions in primary care in the UK: a population-based cross-sectional study.
Abrahami D; McDonald EG; Schnitzer M; Azoulay L
BMJ Open; 2020 Dec; 10(12):e041529. PubMed ID: 33293322
[TBL] [Abstract][Full Text] [Related]
19. Is use of a long-term proton pump inhibitor or histamine-2 receptor antagonist a risk factor for iron-deficiency anaemia in Taiwan? A neglected clinical drug-drug interaction.
Wu YT; Lu YT; Chu CY; Chao HJ; Kuo LN; Cheng KJ; Chen HY
Fam Pract; 2023 Sep; ():. PubMed ID: 37756627
[TBL] [Abstract][Full Text] [Related]
20. Exposure to acid-suppressing drugs during pregnancy and the risk of asthma in childhood: an observational cohort study.
Cea Soriano L; Hernández-Díaz S; Johansson S; Nagy P; García-Rodríguez LA
Aliment Pharmacol Ther; 2016 Feb; 43(3):427-37. PubMed ID: 26612701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]